RRAS: A key regulator and an important prognostic biomarker in biliary atresia

Table 1 Microarray analysis showing clinical characteristics of biliary atresia patients

Case No.	Gender	Age	TB/DB	ALT/AST	AKP/GGT	Albumin	Disease	Group
1	Female	50 d	171/130	132/254	604/609	35.8	BA	1
2	Male	49 d	291/231	148/155	581/408	39.4	BA	1
3	Male	57 d	148/117	189/166	493/535	35.2	BA	1
4	Female	73 d	145/118	111/153	460/1460	36.3	BA	2
5	Male	84 d	160/127	100/149	713/1278	37.3	BA	2
6	Female	66 d	129/108	121/165	632/1235	39.2	BA	2
7	Female	103 d	151/112	85/62	451/360	39.4	BA	3
8	Female	97 d	118/89	74/78	522/501	34.3	BA	3
9	Male	110 d	155/121	105/97	377/912	35.4	BA	3
10	Female	77 d	102/89	201/137	234/317	39.4	Cholestasis	4
11	Male	64 d	137/108	404/267	584/1044	37.2	Cholestasis	4
12	Female	55 d	144/112	389/266	612/1339	41.0	Cholestasis	4
13	Male	4 yr	16/9	33/35	200/50	39.4	Liver trauma	5
14	Male	6 yr	10/4	20/25	192/44	40.1	Liver trauma	5
15	Male	4 yr	12/4.7	29/37	101/38	37.1	Liver trauma	5

TB: Total bilirubin; DB: Direct bilirubin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; AKP: Alkaline phosphatase; GGT: γ-glutamyl transferase; BA: Biliary atresia.